TALK KEYWORD INDEX
This page contains an index consisting of author-provided keywords.
1 | |
16S rRNA gene sequencing | |
2 | |
2x2 | |
4 | |
4pLL model | |
A | |
Aalen-Johansen estimator | |
Abdominal aortic aneurysms | |
Accelerometers | |
accuracy | |
Acinetobacter baumannii | |
acoustic feature | |
action threshold | |
adaptive design | |
adaptive enrichment design | |
adaptive Gauss-Hermite quadrature | |
Adaptive randomisation | |
Adaptive randomization | |
adaptive threshold design | |
adaptive trial design | |
Additional Benefit Assessment | |
additive predictor | |
administrative data | |
adolescents | |
adverse drug events | |
adverse drug reactions | |
adverse events | |
agent-based model | |
agent-based modelling | |
aging | |
AI | |
Air pollutants | |
Alternating recurrent events | |
Alzheimer’s disease | |
Amyotrophic Lateral Sclerosis | |
Analysis | |
analysis population | |
ANCOVA | |
anemia | |
animal experiment | |
Annealed variational inference | |
ANOVA | |
antibiotic resistance | |
anxiety | |
Applicability | |
Approximate Bayesian computation (ABC) | |
Artificial intelligence | |
Artificial Neuron | |
assay sensitivity | |
Association parameter | |
Association structure | |
AUC | |
awake thoracic surgery | |
B | |
Background mortality | |
baseline imbalance | |
basket trial | |
Basket trial design | |
basket trials | |
bayes factor | |
Bayesian | |
Bayesian analysis | |
Bayesian approach | |
Bayesian clinical trial design | |
Bayesian clinical trials design | |
bayesian data assimilation | |
Bayesian decision-theory | |
Bayesian disease mapping | |
Bayesian Factor Analysis for interaction (FIN) | |
Bayesian hierarchical model | |
Bayesian hierarchical modeling | |
Bayesian inference | |
Bayesian joint modeling | |
Bayesian Latent Class Analysis | |
Bayesian methods | |
bayesian model averaging | |
Bayesian modelling | |
Bayesian models | |
bayesian optimal interval design | |
Bayesian P-splines | |
Bayesian Posterior Probabilities | |
Bayesian regression | |
Bayesian statistics | |
Bayesian variable selection | |
baymedr | |
Benchmark | |
Besag York Mollié (BYM) | |
between-individual variance | |
bias | |
Bias (epidemiology) | |
Bias quantification | |
bias-variance trade-off | |
big data | |
binary classification | |
binary outcome | |
Binary outcomes | |
Bioequivalence | |
biomarker | |
biomarker trajectory | |
Biomarker-strategy | |
Biomarkers | |
birth cohorts | |
Birth interval | |
Bivariate toxicity | |
BKMR | |
bladder cancer | |
Blood pressure variability | |
Blood test | |
BMI | |
Bootstrap | |
borrowing from external data | |
bounds | |
Breast cancer | |
Bullous pemphigoid | |
C | |
Calibration | |
Calibration slope | |
Cancer | |
Cancer clinical trial | |
cancer regression | |
cancer screening | |
Cardiomyopathy | |
Cardiovascular | |
Cardiovascular disease | |
Cardiovascular risk | |
Case control | |
case-cohort study | |
Case-control designs | |
Case-control studies | |
causal effect | |
Causal effect direction | |
Causal effect generalization | |
Causal Graph | |
Causal inference | |
Causal mediation analysis | |
Causality | |
Censoring | |
change | |
Charlson Comorbidity Index | |
childhood cancer | |
choroid plexus | |
Chronic diseases | |
Chronological bias | |
circular data | |
Classification | |
classifiers | |
clinical | |
clinical decision making | |
Clinical phase III trials | |
Clinical practice research datalink | |
Clinical prediction | |
Clinical prediction models | |
clinical risk score | |
clinical trial | |
clinical trial analysis | |
clinical trial analysis plans | |
clinical trial design | |
Clinical trial innovation | |
clinical trial reporting | |
Clinical trials | |
Cluster | |
Cluster Analysis | |
cluster level analysis | |
cluster randomisation | |
cluster randomised trial | |
cluster randomised trials | |
cluster randomized Intervention | |
cluster randomized trials | |
cluster stepped wedge | |
cluster-randomised trial | |
Clustered data | |
clustered time-to-event data | |
Clustering | |
Cochrane | |
Cochrane Database of Systematic Reviews | |
Coefficient of determination | |
cognitive bias | |
Cohort design | |
cohort study | |
cohorting | |
collapsibility | |
collider bias | |
colorectal cancer | |
combination therapy | |
Comorbidities | |
comorbidity | |
comparison study | |
Compartmental model | |
Competing risk | |
Competing risks | |
competitive risk | |
Complex interventions | |
composite endpoint | |
computer-aided diagnosis | |
Concordance | |
concordance discordance model | |
Concurrent controls | |
conditional autoregressive (CAR) models | |
Confidence Band | |
Confidence Interval | |
confidence interval estimation | |
Confirmatory factor analysis | |
Confounding Bias | |
Congeniality | |
congenital anomalies | |
consensus building | |
Constrained randomisation | |
contact tracing | |
Continuous monitoring | |
correlated data | |
Correlated test statistics | |
correlation | |
count data | |
Counterfactual | |
counterfactual prediction | |
Covariate measurement | |
covariate selection | |
covariates | |
COVID | |
Covid 19 | |
COVID-19 | |
COVID-19 patients | |
covid19 | |
Cox proportional hazard model | |
Cox proportional-hazards regression | |
Critical care | |
Critical Community Size | |
Cross-classified data | |
Cross-contamination | |
Cumulative incidence functions | |
cumulative link model | |
Cumulative probability of toxicity | |
Cure models | |
cut-point | |
CV risk factors | |
Cystic Fibrosis | |
Czech National Cancer Registry | |
D | |
Data aggregation | |
Data integration | |
data linkage | |
Data quality | |
Data Set Size | |
data sharing | |
Data validation | |
Data visualisation | |
decision curve analysis | |
decision making | |
Decision-making | |
deep generative models | |
deep learning | |
Deep neural network | |
DeepNLME | |
deft interaction | |
Delay in reporting | |
delayed treatment effect | |
Dementia | |
dense longitudinal data | |
dentistry | |
Dependent censoring | |
depression | |
Depth Measures | |
Design-based inference | |
Determinants of Health | |
Device | |
Diabetes Mellitus | |
diabetic nephropathy | |
diagnosis | |
diagnostic accuracy | |
Diagnostic performance | |
diagnostic test | |
Diagnostic test accuracy | |
Diagnostic test evaluation | |
Diagnostic tests | |
DIC | |
differentiable programming | |
differential equations | |
Dimensionality reduction | |
direct and indirect effects | |
disability | |
discrete random effect | |
Disease history | |
Disease mapping | |
Disease progression | |
Disruption | |
distributional regression | |
Distributional shift | |
Diuretics | |
diversity measures | |
Dose-finding | |
Dose-finding study | |
Dose-regimen | |
dose-response | |
Dose-response curves | |
dose-response model | |
dosimetry | |
Double robustness | |
double selection | |
doubly interval-censored | |
Down syndrome | |
Dropout | |
Drug benefit-risk | |
drug development | |
Drug regulation | |
Drug-Related Side Effects and Adverse Reactions | |
Dynamic AUC | |
Dynamic Brier Score | |
Dynamic modelling | |
dynamic models | |
Dynamic prediction | |
Dynamic predictions | |
dynamic structural equation modeling | |
dynamic treatment regimens | |
dynamical systems | |
dysbiosis | |
E | |
early completion | |
Early phase oncology | |
Early-phase clinical trial | |
Ebola virus disease sequelae | |
ECG | |
ECM algorithm | |
EEG Channel Selection | |
EEG Signal Processing | |
effect decomposition | |
effectiveness | |
efficient influence curve | |
Elderly | |
Electronic health record | |
electronic health records | |
Electronic healthcare records | |
Elicitation | |
EM-algorithm | |
Empirical Bayes | |
empirical Bayes estimator | |
Endometriosis | |
endpoint selection | |
endpoints | |
enrichment designs | |
ensemble machine learning | |
Environmental exposure | |
Epidemic Modeling | |
epidemic modelling | |
epidemic monitoring | |
Epidemic renewal equation | |
Epidemiological biases | |
Epidemiological model | |
Epidemiology | |
Epidemiology methods | |
Epigenetic annotations | |
epigenetics | |
equivalence | |
equivalence test | |
error model | |
error rate | |
Estimand | |
Estimation bias | |
Ethics | |
evaluation | |
Evidence synthesis | |
exact test | |
Exaggeration | |
excess hazard | |
excess hazard model | |
Excess mortality | |
expected squared prediction error | |
expedited approval | |
experimental design | |
Experts’ elicitation | |
Explained variation | |
exposomics | |
extended Kalman filter | |
external data | |
External validation | |
external validity | |
extra non-cancer mortality | |
extrapolation | |
F | |
face | |
facial palsy | |
Factor analysis | |
factorial design | |
False Discovery Rate | |
familywise error rate | |
FDA | |
feature extraction | |
feature selection | |
Features Selection | |
Fine-Gray model | |
finite-population correction | |
first type error rate | |
Firth’s correction | |
flexible modeling | |
flexible parametric models | |
Flexible Parametric Survival Model | |
Flipped Classroom | |
Flow of evidence | |
forecast | |
fractional polynomials | |
frailty | |
frailty model | |
Framingham Heart Study | |
frequentist | |
frequentist operating characteristics | |
Full blood count | |
Full Information Maximum Likelihood | |
full matching | |
Functional concurrent regression | |
functional data analysis | |
G | |
g-computation | |
Gaussian process | |
GBM | |
Gene expression | |
generalised Dirichlet distribution | |
generalised estimating equations | |
generalised linear mixed model | |
Generalised linear mixed models | |
generalizability | |
generalized estimating equations | |
generalized functional linear model | |
Generalized gamma distribution | |
Generalized Linear Mixed Model (GLMM) | |
Generalized linear models | |
generalized pairwise comparisons | |
Generalized propensity score | |
Genome wide association study | |
Geometric Brownian motion | |
Gini index | |
GLM | |
Go/No-Go | |
gold-standard | |
Gompertz model | |
gonorrhea | |
Goodness of Fit (GOF) | |
Goodness-of-fit | |
Granularity | |
Graph-theory | |
Group sequential Holm | |
Group sequential tests | |
grouped | |
growth curves | |
Guidelines | |
H | |
Hamiltonian Monte Carlo inference | |
Haplotype reconstruction | |
Hazard ratio | |
Health Data Science | |
health insurance | |
Health-related quality of life | |
healthcare worker screening | |
healthy controls | |
Hematology | |
Hemoadsorption | |
Hepatitis C | |
Heritability | |
heterogeneity | |
Heteroscedasticity | |
hidden markov model | |
hierarchical | |
hierarchical clustering | |
Hierarchical data | |
hierarchical endpoints | |
Hierarchical sparse regression modelling | |
hierarchical testing | |
High-Dimensional Data | |
high-dimensional dataset | |
highly adaptive lasso | |
Historic Controls | |
Historical borrowing | |
Historical controls | |
Historical Data | |
historical data borrowing | |
Historical information | |
HIV | |
HIV biomarkers | |
HIV/AIDS | |
Hong Kong | |
Hospital epidemiology | |
hospital readmissions | |
Human Papillomavirus | |
hyperopia | |
Hypertension | |
hypothesis test | |
Hypothesis tests | |
Hypothetical strategy | |
I | |
iatrogenic complications | |
ICU trials | |
Identification | |
IgA nephropathy | |
Immortal time bias | |
Immortal-time bias | |
Immuno-oncology | |
immunotherapy trial | |
imperfect gold | |
imputation | |
In-hospital mortality | |
Incidence | |
Incidence density sampling | |
Incident-user design | |
Inconsistency | |
incubation time | |
India | |
Indirect evidence | |
individual differences | |
Individual participant data | |
Individual Participant Data Meta-Analysis | |
Individual prediction | |
individual-based modelling | |
individualized prediction models | |
Individualized predictions | |
inequality | |
Infant mortality | |
infection fatality rate | |
Infectious Disease | |
Infectious Diseases | |
influential points | |
information anchoring | |
information sharing | |
information theory | |
informative visit | |
Innovative interpretation methods | |
Innovative methods | |
Instrumental variables | |
inteference | |
intensive longitudinal data | |
Interaction | |
Interactions | |
interactive | |
Interactive graphics | |
Interim analysis | |
International Classification of Diseases | |
Interoperability | |
interpretability | |
Interrupted time series | |
Interval sampling | |
interval-censored data | |
Intervention studies | |
interventional effects | |
Inverse probability of treatment weighting | |
Inverse probability weighting | |
IPD meta-analysis | |
IPTW | |
isolation | |
Item Response Theory | |
J | |
jack-knife | |
Joint model | |
Joint modeling | |
Joint modelling | |
Joint modelling for longitudinal and survival data | |
joint models | |
Joint models for time to event and longitudinal data | |
K | |
Kaplan-Meier test | |
kernel density estimation | |
Kidney function | |
KIR | |
Klebsiella pneumoniae | |
knee society score | |
Kullback-Leibler divergence | |
L | |
lab tests | |
Landmark | |
Landmark analysis | |
Landmark approach | |
Landmark modeling | |
Landmarking | |
Laplace approximations | |
Lasso | |
Last observation carried forward | |
Late-onset toxicity | |
Latency | |
latency time | |
latent class | |
Latent class growth models | |
latent class model | |
Latent Markov models | |
latent variable | |
Latent variable method | |
Latent Variable Models | |
latent variable models with interaction | |
lead-time | |
Learning Curve | |
Left truncation | |
left-truncation | |
Length of stay | |
Length-biased Sampling | |
life expectancy | |
Life table | |
life years lost | |
lifestyle modification | |
Lifetables | |
likelihood penalization | |
lineage | |
linear combination | |
Linear mixed effects model | |
Linear mixed model | |
Linear mixed models | |
Linear mixed-effects models | |
linear regression models | |
Linearity assumptions | |
link function | |
Liver allocation | |
LMPL | |
Local incidence | |
Lockdown | |
Log-rank test | |
Logistic regression | |
longitudinal | |
longitudinal cluster randomized trials | |
longitudinal covariates | |
Longitudinal data | |
Longitudinal data analysis | |
Longitudinal growth model | |
Longitudinal outcome | |
longtudinal models | |
Low outcome rate | |
Lower Limit of Quantification | |
lung cancer | |
M | |
MACE | |
machine learning | |
Machine learning methods | |
Machine Learning models | |
mammography screening | |
mapping | |
marginal and conditional effects | |
Marginal structural models | |
Marginality principle | |
Marginalized Two-part Joint Model | |
Martingale theory | |
Master Protocol | |
Matching | |
maximally selected statistics | |
Maximum Likelihood Method | |
MCP-Mod | |
Mean Residual Life | |
Mean squared error | |
Mean Survival Time | |
measure of separation | |
Measurement error | |
Mecanistic modelling | |
MedDRA | |
medians | |
Mediation | |
mediation analysis | |
Medication effect | |
Mendelian Randomization | |
meta-analysis | |
Meta-analytic-predictive (MAP) | |
Meta-analytic-predictive prior | |
Meta-research | |
Metabolic syndrome | |
Metagenomic analysis of the gut microbiota | |
Method(s) Validation and/or Comparison | |
Methodological development | |
methodological review | |
Methodology | |
Methods comparison | |
mHealth | |
MICE | |
micro-randomized trial | |
Microbiome | |
minimal clinically important difference | |
minimal data | |
Misclassification | |
misclassification costs | |
misfolded protein tau | |
missing | |
Missing data | |
missing evidence | |
Missing indicator | |
Missing not at Random | |
missing outcome data | |
Missing Values | |
mixed | |
mixed censoring | |
Mixed effects location scale models | |
Mixed effects modelling | |
mixed model | |
Mixed models | |
mixture cure models | |
Mixture effect | |
mixture models | |
mobile health | |
model | |
model averaging | |
Model for End-stage Liver Disease (MELD) | |
Model misspecification | |
Model selection | |
Model Sensitivity | |
Model-based analysis | |
Model-Based Clustering | |
modeling | |
Modelling | |
Models | |
modular | |
Molecular quantitative trait locus studies | |
monitoring | |
Monte Carlo simulation | |
Monte-Carlo simulation | |
Mortality | |
MOVER | |
Multi-armed bandits | |
Multi-criteria decision analysis | |
multi-item scale | |
multi-omics data | |
Multi-response model | |
Multi-state model | |
Multi-state modelling | |
multi-state models | |
Multi-task learning | |
Multidimensional mediators | |
Multidrug Resistance | |
multifactorial intervention | |
multilevel | |
Multilevel data | |
multilevel modelling | |
multilevel models | |
multimorbidity | |
Multiple Cox regression analysis | |
multiple imputation | |
multiple mediation analysis | |
Multiple outcomes | |
Multiple primary hypotheses | |
multiple sclerosis | |
multiple testing | |
multiple tests | |
multiple thresholds | |
multiple time points | |
multiple time-point interventions | |
multiplicity correction | |
multistate model | |
Multistate models | |
Multivariable | |
multivariable analysis | |
multivariable model-building | |
Multivariate data | |
Multivariate longitudinal data | |
Multivariate markers | |
Multivariate meta-analysis | |
multivariate Student-t distribution | |
mutant | |
N | |
national clinical datasets | |
Natural Language Processing | |
Negative control outcomes | |
Negative Predictive Value | |
neonates | |
nephrology | |
Nested case-control design | |
net benefit | |
Net survival | |
network | |
network analysis | |
Network meta-analysis | |
network meta-regression | |
neural differential equations | |
Neural Networks | |
neurodegenerative disease | |
Neurodegenerative Diseases | |
Next generation sequencing | |
NGS | |
non-adherance | |
Non-compartmental analysis | |
non-convex optimization | |
non-homogenuous Poisson model | |
non-ignorable | |
non-inferiority | |
non-inferiority trials | |
non-intubated lung resection | |
non-intubated VATS lobectomy | |
non-linear mixed effects model | |
non-normal random effect | |
Non-proportional hazards | |
Non-Small-Cell Lung Carcinoma | |
non-stationarity | |
Nonlinear mixed effects models | |
Nonlinear mixed models | |
nonparametric | |
nonparametric Bayesian methods | |
Nonparametric methods | |
North Rhine-Westphalia | |
nosocomial transmission | |
nowcast | |
O | |
O2PLS | |
observational data | |
Observational evidence | |
observational studies | |
Observational study | |
obstructive sleep apnea | |
ODE-based models | |
Omics | |
Omics integration | |
oncology | |
Oncology trials | |
open cohort | |
opioids | |
optimal design | |
optimum dose | |
Oral prednisolone | |
ordered probit model | |
ordinal | |
ordinal data | |
ordinal endpoints | |
ordinal outcome | |
ordinal regression | |
Ordinary Differential Equations | |
osteoarthritis | |
Osteosarcoma | |
outcome measurement | |
Overrunning | |
P | |
P-values | |
Paediatric ophthalmology | |
Pain management | |
Pain Therapy | |
paired data design | |
Pandemic curve flattening | |
Parametric inference | |
Partly conditional transition rate | |
path analysis | |
pathological voice | |
Patient allocation | |
patient identifiers | |
Patient preference | |
patient-level covariate | |
patient-reported outcome | |
patients' heterogeneity | |
PCA | |
pediatric cancer | |
Pediatrics | |
Penalised generalised linear models | |
penalized likelihood | |
penalized log-likelihood | |
Penalized logistic regression | |
Penalized natural spline | |
Perfect Tree | |
Performance | |
Performance measures | |
personal protective equipment | |
Personalised Medicine | |
personalized medicine | |
personalized prediction models | |
Personalized randomisation | |
PET/CT medical imaging | |
Pharmaco-epidemiology | |
Pharmacoepidemiology | |
Pharmacokinetics | |
Pharmacokinetics/pharmacodynamics | |
pharmacometrics | |
pharmacovigilance | |
phase I cancer clinical trials | |
phase II trials | |
phenomenological models | |
Physical activity | |
Physical education | |
platform trial | |
Platform trial design | |
Platform trials | |
PLS-DA | |
Pneumonia | |
Poincare plots | |
point estimation | |
Poisson Distribution | |
Poisson Model | |
Polygenic risk | |
Polygenic risk scores | |
polynomial trend | |
Pompe disease | |
Population Attributable Fraction | |
population based | |
population based cancer registry | |
population finding | |
population-based cohort study | |
Positive Predictive Value | |
Post-selection inference | |
Post-test Predictive Probability | |
post-treatment score | |
potential survival | |
power | |
Power calculation | |
Power prior | |
pragmatic trials | |
Pre-hospital Care | |
Pre-test Predictive Probability | |
Precision medicine | |
precision oncology | |
Precision/personalized medicine | |
Preclinical to human extrapolation | |
prediction | |
Prediction accuracy | |
Prediction model | |
Prediction Models | |
predictive modeling | |
Predictive modelling | |
predictive models | |
Predictive performance | |
Predictive probability of success | |
predictive values | |
Preference-based health measure | |
Prescription-based drug exposure | |
preterm infant | |
Prevalent Cohort | |
Prevalent-user design | |
principal stratification | |
Prior distributions | |
Prior information | |
Prior-data conflict | |
prioritized outcomes | |
Probabilistic data integration | |
probabilistic linkage | |
Probability estimation | |
Probability machine | |
Probiotics | |
probit link | |
prognistic index evaluation | |
prognosis | |
Prognostic factors | |
Prognostic model | |
Projection-based estimation | |
Propensity score | |
propensity score matching | |
Propensity scores | |
proportional hazards assumption | |
Proportional Hazards Models | |
Proportional hazards regression | |
proportional odds model | |
Prospective study | |
Prostate cancer | |
pseudo individual participant data | |
pseudo-observations | |
Pseudomonas aeruginosa | |
psychiatry | |
public health | |
Public health modelling | |
Pulmonary Exacerbation | |
Q | |
Quality control | |
quality of life | |
quantile regression | |
Quantitative exposure | |
Quarantine | |
questionnaires | |
R | |
R implementation | |
R package | |
Radiomics | |
Random coefficients approach | |
random effect models | |
random effects | |
random forest | |
Random Forests | |
Random slopes models | |
Random Survival Forest | |
Random walks | |
randomised control trials | |
Randomised controlled trial | |
randomised controlled trials | |
Randomization | |
randomization inference | |
randomized | |
Randomized Clinical Trials | |
randomized controlled trial | |
Randomized controlled trials | |
randomized experiments | |
Ranking | |
Rapid review | |
Rare disease | |
rare diseases | |
Ratios | |
RCT | |
RCTs | |
Re-analysis | |
Real world data | |
real world evidence | |
Real-world data | |
Real-World evidence | |
record linkage | |
Recurrent events | |
recurrent events duration | |
Recurrent-event-models | |
Registries | |
Registry analysis | |
registry data | |
registry-based data | |
registry-based studies | |
registry-based study | |
regression | |
regression analysis | |
Regression calibration | |
Regression models | |
regression splines | |
Reinke’s edema | |
Relative survival | |
repeated measures | |
reporting | |
reporting bias | |
reporting delay | |
Reporting guidelines | |
Representation Learning | |
Reproducibility of research | |
reproduction number | |
Reproductive number | |
resampling | |
Residential history | |
resilience | |
resting state fMRI | |
Restricted Bayes | |
restricted mean time lost | |
Retro-prospective | |
retrospective cohort study | |
Reverse causality | |
review | |
Ridge regression | |
ridge regression models | |
Right Censoring | |
right-truncation | |
risk classification | |
risk difference | |
risk factors | |
Risk of Bias | |
risk prediction | |
Risk prediction models | |
robust filtering | |
Robust standard error | |
robustness | |
ROC curve | |
Rshiny | |
S | |
safety | |
sample size | |
sample size calculation | |
Sampling variability | |
SAR models | |
SARS-CoV-2 | |
SARS-CoV-2 infection | |
SARS-Cov2 | |
school-based | |
Screening | |
Screening and surveillance | |
Seamless design | |
seamless phase I/II trial | |
secondary data | |
segmented regression | |
SEIR | |
SEIR model | |
selection bias | |
selective inference | |
self-isolation threshold | |
semi-competing risks | |
Semi-Continuous | |
semi-structured data | |
semisupervised learning | |
sensitivity | |
Sensitivity analyses | |
Sensitivity analysis | |
separation | |
sequential Cox approach | |
sequential multiple assignment randomised trial | |
SF-6D | |
shape index | |
Shared decision making | |
Shrinkage | |
simmilarities | |
Simulation | |
simulation analysis | |
Simulation studies | |
Simulation study | |
Simulation-Extrapolation | |
Simulations | |
single-cells RNA-seq | |
SIR | |
skewed outcome | |
Skin Neoplasms | |
small area estimation | |
small clinical trials | |
small number of clusters | |
Small sample corrections | |
small samples | |
socio-economic inequalities | |
SOFA score | |
software | |
Software packages | |
South Africa | |
Sparse design | |
spatial analysis | |
Spatial Autocorrelation | |
Spatial Clustering | |
spatial effects | |
spatiotemporal models | |
split-mouth study | |
spontaneous activations | |
standard gamble | |
standardised incidence ratio | |
Standardization | |
state space model | |
Statins | |
statistical analysis of clinical trials | |
statistical computing | |
statistical estimation | |
Statistical genetics | |
Statistical Information | |
Statistical modelling | |
statistical power | |
statistical significance | |
Statistical Software | |
stepped wedge | |
Stepped Wedge Design | |
stepped wedge trials | |
Stepped-wedge design | |
stereotype logistic model | |
stochastic processes | |
stratification | |
stratified | |
Stratified randomisation | |
Stroke | |
Structural equation model | |
Structural equation modeling | |
study design | |
subfertility | |
subgroup analysis | |
Subgroup Identification | |
subgroup-specific treatment effects | |
subgroups | |
Subject-specific networks | |
subjective psychosomatic symptoms | |
Subpopulation selection | |
subpopulations | |
subsequent primary neoplasms | |
Sufficient Follow-Up | |
Summary genetic data | |
Super learner | |
superiority | |
Supervised Machine Learning | |
surgery | |
Surrogacy | |
surrogacy validation | |
Surrogate endpoint | |
surrogate endpoints | |
surrogate marker | |
surrogate outcomes | |
survival | |
Survival Analysis | |
Survival data | |
Survival data analysis | |
survival model | |
Survival models | |
Survival outcomes | |
SW-CRT | |
synergistic and non linear association | |
Systematic review | |
Systematic reviews | |
T | |
Tailored Bayesian methods | |
target trial | |
target trial emulation | |
targeted causal inference | |
Targeted Maximum Likelihood Estimation | |
targeted maximum likelihood estimation (TMLE) | |
Teaching Biometry | |
telemonitoring data | |
temporal data | |
Temporal relationships | |
therapeutic threshold | |
Three-level data | |
threshold analysis | |
threshold estimation | |
time series | |
time series analysis | |
Time to event analysis | |
Time trend | |
Time-dependant confounding | |
Time-dependent confounding | |
time-dependent covariate | |
time-dependent remission | |
Time-lag bias | |
Time-series | |
Time-to-cure | |
time-to-event | |
Time-to-event analysis | |
time-to-event data | |
time-to-event outcome | |
Time-to-event outcomes | |
Time-varying confounding | |
time-varying effect | |
Time-varying exposures | |
Time-varying treatment | |
Tipping Point | |
tolerance | |
topological data analysis | |
total knee replacement surgery | |
Toxicity | |
Toxicology | |
Trajectories | |
trajectory | |
transition | |
Transition probabilities | |
transportability | |
Trauma | |
Traumatic brain injury | |
treatment effect | |
treatment effect heterogeneity | |
Treatment effects | |
Treatment rankings | |
treatment selection marker | |
treatment selection score | |
treatment timing | |
treatment-covariate interactions | |
tree-based models | |
tree-lasso | |
trial | |
trial data | |
Trimmed means | |
tubeless anaesthesia | |
Tuberculosis | |
Tuberous sclerosis complex | |
tumor growth | |
Tuning | |
type I error | |
Type M error | |
Type S error | |
type-I error probability | |
type-one error | |
U | |
Umbrella trial | |
Uncertainty Interval | |
Uncertainty Measure | |
Underreporting | |
universal differential equations | |
unmeasured confounding | |
unsupervised learning | |
Up-to-date survival predictions | |
Updating | |
V | |
Vaccine | |
Vaccines | |
validation | |
valvular heart disease | |
Variable selection | |
variance | |
Variance estimator | |
variance modelling | |
variance models | |
Variational methods | |
varying coefficient | |
very high CV risk | |
Virtual biopsy | |
W | |
WAIC | |
wearable devices | |
web tool | |
web-app | |
Weighted analysis | |
Weighted log-rank test | |
weighted log-rank tests | |
Well-defined research question | |
Whole genome sequencing | |
wilcoxon van elteren test | |
Wild bootstrap | |
within-person trial | |
WOMAC score | |
Women empowerment | |
Word-embedding | |
X | |
Xenoestrogens | |
Y | |
Youden index | |
Z | |
Zero-inflated | |
zero-inflation |